Chen Xin Pharmaceutical announced that as of the date of this announcement, shareholder Han Yanzhen held 21,269,329 shares of the company, accounting for 4.698% of the company's total share capital; it had released the pledge of 11,340,000 shares on 2025.12.31, accounting for 53.32% of its shares and 2.50% of the company's total share capital, and 0 shares remaining pledged after cancellation.

Chen Xin Pharmaceutical announced that as of the date of this announcement, shareholder Han Yanzhen held 21,269,329 shares of the company, accounting for 4.698% of the company's total share capital; it had released the pledge of 11,340,000 shares on 2025.12.31, accounting for 53.32% of its shares and 2.50% of the company's total share capital, and 0 shares remaining pledged after cancellation.